The Gut-Brain Axis in Parkinson’s Disease: Possibilities for Food-Based Therapies

Perez-Pardo, Paula, Kliest, Tessa, Dodiya, Hemraj B., Broersen, Laus M., Garssen, Johan, Keshavarzian, Ali, Kraneveld, Aletta D.·2017·European Journal of Pharmacology
DOI 10.1016/j.ejphar.2017.05.042

Cited by (201)

Items 101–200 of 201

  1. Gut–Brain Axis: Potential Factors Involved in the Pathogenesis of Parkinson's Disease
    Yinxia Chao, Muhammad Yaaseen Gulam, Nicholas Shyh Jenn Chia, Lei Feng, Olaf Rötzschke, Eng‐King Tan · 2020 · Frontiers in Neurology
  2. Gut brain axis: an insight into microbiota role in Parkinson’s disease
    Sara Ayman Moustafa, Shrouk M. Abdou, Abdelhameed S. Dawood, Jihan Azar, Ekramy Mahmoud Elmorsy, Noura Rizk, Mohamed Salama · 2021 · Metabolic Brain Disease
  3. Gut microbiota axis: potential target of phytochemicals from plant-based foods
    Ruyu Shi, Congying Huang, Yuan Gao, Xing Li, Chunhong Zhang, Minhui Li · 2023 · Food Science and Human Wellness
  4. 16S rRNA gene profiling and genome reconstruction reveal community metabolic interactions and prebiotic potential of medicinal herbs used in neurodegenerative disease and as nootropics
    Christine Tara Peterson, Vandana Sharma, Stanislav N. Iablokov, Levent Albayrak, Kamil Khanipov, Sasha Uchitel, Deepak Chopra, Paul J. Mills, Yuriy Fofanov, Dmitry A. Rodionov et al. · 2019 · PLoS ONE
  5. Iso‐α‐acids, the bitter components of beer, improve hippocampus‐dependent memory through vagus nerve activation
    Yasuhisa Ano, Ayaka Hoshi, Tatsuhiro Ayabe, Rena Ohya, Shinichi Uchida, Kôji Yamada, Keiji Kondô, Shiho Kitaoka, Tomoyuki Furuyashiki · 2019 · The FASEB Journal
  6. Norepinephrine depleting toxin DSP-4 and LPS alter gut microbiota and induce neurotoxicity in α-synuclein mutant mice
    Sheng Song, Jie Liu, Feng Zhang, Jau‐Shyong Hong · 2020 · Scientific Reports
  7. An infection of Enterobacter ludwigii affects development and causes age-dependent neurodegeneration in Drosophila melanogaster
    Subhashree Priyadarsini, Sahoo Moumita, Swetapadma Sahu, R. Jayabalan, Monalisa Mishra · 2019 · Invertebrate Neuroscience
  8. Association between Parkinson’s disease and the faecal eukaryotic microbiota
    Severin Weis, Alexandra Meisner, Andreas Schwiertz, Marcus Michael Unger, Anouck Becker, Klaus C Fassbender, Sylvia Schnell, Karl‐Herbert Schäfer, Markus Egert · 2021 · npj Parkinson s Disease
  9. Intrastriatal injection of Parkinson’s disease intestine and vagus lysates initiates α-synucleinopathy in rat brain
    Zhaofei Yang, Ying Wang, Min Wei, Song Li, Congcong Jia, Cheng Cheng, Murad Al‐Nusaif, Jun Zhang, Cong Liu, Weidong Le · 2023 · Cell Death and Disease
  10. Effects of a probiotic suspension Symprove™ on a rat early-stage Parkinson’s disease model
    Marco Sancandi, Carmen De Caro, Neringa Cypaite, Nadia Marascio, Carmen Avagliano, Carmela De Marco, Emilio Russo, Andrew Constanti, Audrey Mercer · 2023 · Frontiers in Aging Neuroscience
  11. Parkinson’s disease: what the model systems have taught us so far
    Swagata Ghatak, Dorit Trudler, Nima Dolatabadi, Rajesh Ambasudhan · 2018 · Journal of Genetics
  12. Pathogenesis from the microbial-gut-brain axis in white matter injury in preterm infants: A review
    Yuqian Wang, Jing Zhu, Ning Zou, Li Zhang, Yingjie Wang, Mengmeng Zhang, Chan Wang, Liu L. Yang · 2023 · Frontiers in Integrative Neuroscience
  13. Antibiotic Consumption Patterns in European Countries Are Associated with the Prevalence of Parkinson’s Disease; the Possible Augmenting Role of the Narrow-Spectrum Penicillin
    Gábor Ternák, Márton Németh, Martin Rozanovic, Gergely Márovics, Lajos Bogár · 2022 · Antibiotics
  14. Engineered Probiotic and Prebiotic Nutraceutical Supplementations in Combating Non-communicable Disorders: A Review
    Rout George Kerry, Gitishree Das, Upendarrao Golla, María del Pilar Rodríguez-Torres, Han‐Seung Shin, Jayanta Kumar Patra · 2020 · Current Pharmaceutical Biotechnology
  15. Perspective: Low Risk of Parkinson's Disease in Quasi-Vegan Cultures May Reflect GCN2-Mediated Upregulation of Parkin
    Mark Frederick McCarty, Aaron Lerner · 2020 · Advances in Nutrition
  16. The gut-brain connection in the pathogenicity of Parkinson disease: Putative role of autophagy
    Violina Kakoty, K C Sarathlal, Sunil Kumar Dubey, Chih Hao Yang, Prashant Kesharwani, Rajeev Taliyan · 2021 · Neuroscience Letters
  17. Diet Quality is Associated with Prodromal Parkinson's Disease Features in Chinese Adults
    Xinyuan Zhang, Jipo Xu, Yesong Liu, Shuohua Chen, Shouling Wu, Xiang Gao · 2022 · Movement Disorders
  18. Effects of dietary supplements, foods, and dietary patterns in Parkinson’s disease: meta-analysis and systematic review of randomized and crossover studies
    Wu, Lingyu, Chu, Liwen, Pang, Yufei, Huo, Jinghong, Cao, Hongdou, Tian, Qi, Gao, Qinghan · 2024 · European Journal of Clinical Nutrition
  19. The gut-brain axis and gut inflammation in Parkinson’s disease: stopping neurodegeneration at the toll gate
    Anastazja M. Gorecki, Sarah A. Dunlop, Jennifer Rodger, Ryan S. Anderton · 2020 · Expert Opinion on Therapeutic Targets
  20. Age-dependent elevations of oligomeric and phosphorylated alpha-synuclein synchronously occurs in the brain and gastrointestinal tract of cynomolgus monkeys
    Xin Li, Weiwei Yang, Xuran Li, Min Chen, Cheng‐Wei Liu, Shun Yu · 2017 · Neuroscience Letters
  21. Aerobic Exercise and Healthy Nutrition as Neuroprotective Agents for Brain Health in Patients with Parkinson’s Disease: A Critical Review of the Literature
    Davide Maria Cammisuli, Ubaldo Bonuccelli, Simona Daniele, Claudia Martini, Jonathan Fusi, Ferdinando Franzoni · 2020 · Antioxidants
  22. Compound Dihuang Granule Changes Gut Microbiota of MPTP-Induced Parkinson’s Disease Mice via Inhibiting TLR4/NF-κB Signaling
    Zhu-qing He, Peng-fei Huan, Li Wang, Jiancheng He · 2023 · Neurochemical Research
  23. Significance of vagus nerve function in terms of pathogenesis of psychosocial disorders
    Yoshihiko Kakinuma · 2020 · Neurochemistry International
  24. Bioavailability and Health Impact of Ingested Amyloid‐like Protein Fibrils and their Link with Inflammatory Status: A Need for More Research?
    Trui Luyckx, Charlotte Grootaert, Margarita Monge‐Morera, Jan A. Delcour, Frédéric Rousseau, Joost W. H. Schymkowitz, John Van Camp · 2022 · Molecular Nutrition & Food Research
  25. Palm Fruit Bioactives augment expression of Tyrosine Hydroxylase in the Nile Grass Rat basal ganglia and alter the colonic microbiome
    Robert P. Weinberg, Vera V. Koledova, Avinaash Subramaniam, Kirsten Schneider, Anastasia Artamonova, Ravigadevi Sambanthamurthi, K. C. Hayes, Anthony J. Sinskey, ChoKyun Rha · 2019 · Scientific Reports
  26. Exploring Gut–Brain Interaction Disorders: Mechanisms and Translational Therapies Crossing Neurology to Gastroenterology
    Georgi Vasilev, Dimitrina Miteva, Milena Gulinac, Lyubomir Chervenkov, Meglena Kitanova, Tsvetelina Veselinova Velikova · 2024 · Gastroenterology Insights
  27. Galantamine-Memantine Combination in the Treatment of Parkinson’s Disease Dementia
    Emma D. Frost, Swanny X. Shi, Vishnu Vardhan Byroju, Jamir Pitton Rissardo, Jack Donlon, Nicholas F. Vigilante, Briana P. Murray, Ian M. Walker, Andrew J. McGarry, Thomas N. Ferraro et al. · 2024 · Brain Sciences
  28. The Mitochondrial Ribosome: A World of Opportunities for Mitochondrial Dysfunction Toward Parkinson's Disease
    Ana Mafalda Rodrigues Gonçalves, A. Raquel Pereira-Santos, A. Raquel Esteves, Sandra M. Cardoso, Nuno Empadinhas · 2020 · Antioxidants and Redox Signaling
  29. What Can Inflammation Tell Us about Therapeutic Strategies for Parkinson’s Disease?
    Jinsong Xue, Keju Tao, Weijia Wang, Xiaofei Wang · 2024 · International Journal of Molecular Sciences
  30. Angiotensin (1–7) Expressing Probiotic as a Potential Treatment for Dementia
    Abbi R. Hernandez, Anisha Banerjee, Christy S. Carter, Thomas W. Buford · 2021 · Frontiers in Aging
  31. An overview of the neuroendocrine system in Parkinson’s disease: what is the impact on diagnosis and treatment?
    Agata Mulak · 2019 · Expert Review of Neurotherapeutics
  32. Advances in autonomic dysfunction research in Parkinson’s disease
    Hongjia Xu, Xiaolei Zheng, Xinyue Xing, Zhu Bi, Dewei Wang, Cheng Zhang, LiFei Wei, Yulin Jin, Shunliang Xu · 2025 · Frontiers in Aging Neuroscience
  33. Zeolite and Neurodegenerative Diseases
    Stefan Panaiotov, Lyubka P. Tancheva, Reni E. Kalfin, Polina S. Petkova-Kirova · 2024 · Molecules
  34. Cold‐pressed perilla seed oil: Investigating its protective influence on the gut–brain axis in mice with rotenone‐induced Parkinson's disease
    Peerapa Techaniyom, Chawin Korsirikoon, Thanaporn Rungruang, Narawut Pakaprot, Pinidphon Prombutara, Sujira Mukda, Aikkarach Kettawan, Aikkarach Kettawan · 2024 · Food Science & Nutrition
  35. The role of the gut microbiota in neuropsychiatric disorders and therapy
    Fan Zhang, Kang Ding, Linmei Zhang, Dongyao Liu, Xin Dong, Man‐Ni Wang, Fu-Lin Zhou, Yi‐Wei Sun, Wei‐Ku Zhang, Yan Yu et al. · 2025 · Ageing Research Reviews
  36. Oral administration of PET tracers: Current status
    Giordana Salvi de Souza, Dimitri Brigide de Almeida Mantovani, Pascalle Mossel, Bartholomeus C. M. Haarman, Ana Maria Marques da Silva, Hendrikus Hessel Boersma, Cristiane Regina Guerino Furini, Adriaan A. Lammertsma, Charalampos Tsoumpas, Gert Luurtsema · 2023 · Journal of Controlled Release
  37. Prebiotics and probiotics and Parkinson's disease
    Reza Amani, Sanaz Mehrabani · 2023 · Elsevier eBooks
  38. Sourdough bread as nutritional intervention tool for improvement of cognitive dysfunction in diabetic rats
    Doha Abdou Mohamed, Karem Aly Fouda, Hoda Bakr Mabrok, Marwa El-Sayed El-Shamarka, Ibrahim Mohamed Hamed · 2024 · BMC Nutrition
  39. Differential contribution of estrogen receptors to the intestinal therapeutic effects of 17β-estradiol in a murine model of Parkinson’s disease
    Andrée-Anne Poirier, Mélissa Côté, Mélanie Bourque, Hend Jarras, Jérôme Lamontagne‐Proulx, Marc Morissette, Thérèse Di Paolo, Denis Soulet · 2022 · Brain Research Bulletin
  40. Microbiota–Gut–Brain Axis: Pathophysiological Mechanism in Neuropsychiatric Disorders
    Cheolmin Shin, Yong‐Ku Kim · 2023 · Advances in experimental medicine and biology
  41. The intestinal luminal sources of α-synuclein: a gastroenterologist perspective
    Aaron Lerner · 2021 · Nutrition Reviews
  42. Disease mechanisms as subtypes: Microbiome
    Salvatore Bonvegna, Roberto Cilia · 2023 · Handbook of clinical neurology
  43. Enzyme Immunoassay-Based Platform for Accurate Detection of Serum Pathological α-Synuclein in Parkinson’s Disease Patients
    Benjamin William Schlichtmann, Naveen Chandra Kondru, Monica Hepker, Anumantha G. Kanthasamy, Vellareddy Anantharam, Manohar John, Bhupal Ban, Surya K. Mallapragada, Balaji Narasimhan · 2020 · ACS Chemical Neuroscience
  44. Fecal Microbiota Transplantation Decreases Amyloid Load and Improves Cognition in Alzheimer’s
    Shalini Elangovan, Thomas Julius Borody, R. M. Damian Holsinger · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
  45. Nutraceuticals Unveiled a Multifaceted Neuroprotective Mechanisms for Parkinson’s Disease: Elixir for the Brain
    Divya Soni, Sumit Jamwal, Rakesh Chawla, Sachin Kumar Singh, Deependra Singh, Thakur Gurjeet Singh, Navneet Khurana, Abhinav Kanwal, Harish Dureja, Umesh Kumar Patil et al. · 2024 · Food Reviews International
  46. The brain-gut axis: communication mechanisms and the role of the microbiome as a neuroprotective factor in the development of neurodegenerative diseases: A literature overview
    Natalia Białoń, dr hab. n. o zdr. Dariusz Górka, Mikołaj Górka · 2024 · AIMS neuroscience
  47. Disease modifying therapies for Parkinson's disease: Novel targets
    Nirosen Vijiaratnam, Thomas Foltynie · 2021 · Neuropharmacology
  48. Gut-brain axis as a key aspect of clinical conditions
    Sarah de Oliveira Rodrigues, Alice Garcia Pádua, Clara Mariana Gonçalves Lima, Rebecca de Oliveira Rodrigues, Isabela Bacelar de Assis, Jorge Pamplona Pagnossa · 2022 · International Journal of Family & Community Medicine
  49. A combined microphysiological-computational omics approach in dietary protein evaluation
    Paulus G. M. Jochems, Willem R. Keusters, Antoine H. P. America, Pascale C. S. Rietveld, Shanna Bastiaan‐Net, Renata M.C. Ariëns, Monic M. M. Tomassen, Fraser Iain Lewis, Yang Li, Koen G.C. Westphal et al. · 2020 · npj Science of Food
  50. Comparison of phage and plasmid populations in the gut microbiota between Parkinson’s disease patients and controls
    Ilhan Cem Duru, Alexandre Lecomte, Pia Laine, Tânia Keiko Shishido, Joni Suppula, Lars G. Paulin, Filip Scheperjans, Pedro A. B. Pereira, Petri Auvinen · 2025 · Scientific Reports
  51. Butyrate-Modified Hyaluronic Acid Ameliorates MPTP-Induced Parkinson’s Disease via Modulating PINK1/Parkin-Involved Mitophagy and Intestinal Flora
    Yu Sun, Li Hong Cui, Wanqiu Peng, Rong Chen, Xueneng Guan, Jiangyun Liu · 2025 · Biomacromolecules
  52. Gut Microbes in Parkinson's Disease
    Anastasia Markidi, Joshua D. Elford, Celia R. Berkers, Aletta D. Kraneveld, Paula Perez‐Pardo · 2024 · Elsevier eBooks
  53. Effectiveness of 7-chloro-4-(phenylselanyl) quinoline in improving learning, short-term memory, and anxiety-like behaviors in a mimetic model of Parkinson's disease in Drosophila melanogaster
    Shanda de Freitas Couto, Stífani Machado Araújo, Vandreza Cardoso Bortolotto, Mustafa Munir Mustafa Dahleh, Elize Aparecida Santos Musachio, Franciane Cabral Pinheiro, Leugim Corteze Romio, Manoela Sacramento, Diego A.C. Alves, Marina Prigol · 2022 · New Journal of Chemistry
  54. Potential Role of Probiotics and Fecal Microbiota Transplantation in the Treatment of Parkinson's Disease
    Bilal El‐Mansoury, Kamal Smimih, Abdelaati El Khiat, Hanane El Fatimi, Abdelmohcine Aimrane, Soraia El Baz, Abdessamad Elmourid, Fatima Ez-Zahraa Saad, Hafida El Ghachi, Manal Khanouchi et al. · 2023 · Advances in medical diagnosis, treatment, and care (AMDTC) book series
  55. Functional and molecular early enteric biomarkers for Parkinson’s disease in mice and men
    Manuela Gries, Anne Christmann, Steven Schulte, Maximilian Weyland, Stephanie Rommel, Monika Martin, Marko K. Baller, Ralph Röth, Stefanie Schmitteckert, Marcus Michael Unger et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  56. Exploring the Role of Food and Food-Related Compounds in Parkinson’s Disease
    Ilaria Trezzi, Gianluca Rizzo, Francesca Giampieri, Maurizio Antonio Battino, Luciana Baroni · 2026 · Foods
  57. Psychobiotics in Health, Longevity, and Neurological Disorders
    Amirthalingam Mohankumar, D. Kalaiselvi, Govindhan Thiruppathi, Duraisamy Patteswari, Shinkichi Tawata, Palanisamy Sundararaj · 2022 · Nutritional neurosciences
  58. Role of the microbiome in the development of Parkinson's disease (Review)
    Sofjana Gushi, Stavros Derdas · 2025 · World Academy of Sciences Journal
  59. Wpływ mikrobiomu jelitowego na mózg i psychikę
    Jagna Żakowicz, Aleksandra Bramorska, Wanda Zarzycka, Anna Kovbasiuk, Katarzyna Kuć, Aneta Brzezicka · 2020 · Kosmos
  60. Animal Models Used for Studying the Benefits of Probiotics in Neurodegeneration
    Gangaraju Divyashri, S. G. Prapulla · 2022 · Springer eBooks
  61. Microbiome-Based Therapies in Parkinson’s Disease: Can Tuning the Microbiota Become a Viable Therapeutic Strategy?
    Adejoke Y. Onaolapo, Folusho O. Ojo, Anthony Tope Olofinnade, Joshua Falade, Ismail Adetayo Lawal, Olakunle J. Onaolapo · 2022 · CNS & Neurological Disorders - Drug Targets
  62. Royal jelly - a potential for healthy lifestyle
    Ivy Neha Chander, Lovleen · 2021 · Journal of Entomological Research
  63. The Double‐Edged Sword: The Complex Function of Enteric Glial Cells in Neurodegenerative Diseases
    Ingrid Prata Mendonça, Christina Alves Peixoto · 2025 · Journal of Neurochemistry
  64. The Gut-Brain Axis: A Critical Link between Type 2 Diabetes and Parkinson’s disease
    Najlaa H. Almohmadi, Hayder M. Al‐kuraishy, Khulood S. Hussein, Arwa Turkistani, Fatimah M. Yousef, Ali Ismail Al-Gareeb, Ahmed M Abdelaziz, Yaser Hosny Ali Elewa, Gaber El‐Saber Batiha · 2026 · Probiotics and Antimicrobial Proteins
  65. Association Between Serum Galectin‐3 and Parkinson's Disease: A Two‐Sample Mendelian Randomization Study
    Rui Pan, Wei Li, Jinyuan Wang, Jiarong Xie, Xiucan Weng, Ying Xue Yang, Xiaolei Shi · 2024 · Brain and Behavior
  66. The Role of Inflammation in Early and Late Phase of Parkinson Disease
    Mohammed Mosaad, Abeer Furayj Aljahdali · 2021 · Pharmacophore
  67. Emerging Relationship Between the Gut Microbiota and Neurodegenerative Disorders
    Shreyas Iyer, Shreya Verma, Sandhya Amol Marathe, Meghana Tare · 2024 · Springer eBooks
  68. Light Therapy in Parkinson’s Disease
    Michael Besser AM · 2022 · Biomedical Journal of Scientific & Technical Research
  69. EFFECTS OF CLOSTRIDIUM BUTYRICUM SUPPLEMENTATION ON FECAL MICROBIOTA AND METABOLITES IN CAPTIVE RED KANGAROO (MACROPUS RUFUS)
    Yuto Yoshimoto, Natsumi Ichinohe, Hong Liu, Noriko Nagata, Ryo Inoüe, Yuki Yamamoto, Kentaro Nagaoka · 2025 · Journal of Zoo and Wildlife Medicine
  70. Early alpha-synuclein accumulation, oxidative stress and inflammation in the proximal colon of c-rel-/- mouse model of Parkinson's disease
    Edoardo Parrella, Michele Mario Gennari, Giulia Abate, Mariachiara Pucci, Tiziana Schioppa, Daniela Bosisio, Emanuela Tirelli, Marina Benarese, Gaia Vegezzi, Maria Silletti et al. · 2025 · Neurobiology of Disease
  71. Marine Bioactive Components and Chronic Neuroinflammation: Focus on Neurodegenerative Disease
    Elda Favari, Cinzia Parolini · 2025 · Marine Drugs
  72. Probiotics and aging: Impacts on cognitive function, brain-derived neurotrophic factor, inflammation, and antioxidant activity. A systematic review and meta-analysis
    Yvonne Suzy Handajani, Yuda Turana, Antoninus Hengky, Kevin Kristian · 2026 · Journal of Alzheimer s Disease
  73. The Influence of Gut Microbiome on Alpha-Synuclein Aggregation: Implications for Parkinson’s Disease Pathogenesis
    Muskan Sain, Shital Rani, Suraj Singh, Pritiman Pothal, Shubham Yadav, Ashish Suttee, Akhilesh Kumar, Santosh Kumar, Pavitra Ranawat, Gurpal Singh et al. · 2026 · Molecular Neurobiology
  74. Microbiota–Gut–Brain Axis and Neurodegenerative Disorder
    Awakash Soni, Ankit Verma, Priya Gupta · 2022 · Nutritional neurosciences
  75. Personalized Response of Parkinson’s Disease Gut Microbiota to Nootropic Medicinal Herbs In Vitro: A Proof of Concept
    Christine Tara Peterson, Stanislav N. Iablokov, Dmitry A. Rodionov, Scott N. Peterson · 2023 · Microorganisms
  76. Mental health screening in patients with type-2 diabetes mellitus
    Diana María Igua Ropero, Deysy Katherinn Manosalva Dallos, María Alejandra Velásquez Sandoval, Jhon Albeiro Lagos Naranjo · 2023 · Journal of Diabetes Metabolic Disorders & Control
  77. Potential role of probiotics for neurological disease treatment
    Khushi Quadri, Renu Kadian, Sagar Thakur, Sushma Chaturvedi, Geeta Rawat, Aafrin Waziri, Md Sabir Alam · 2024 · Elsevier eBooks
  78. Research progress on the regulation of gut microbiota by Chinese yam polysaccharides
    Ting Hu, Peng Wu, Jianfeng Zhan, Weixin Wang · 2024 · Journal of Food Bioactives
  79. The bioengineering of stem cells to create dopamine replacement neurons is not the solution for Parkinson's
    Robert J. Carey, Jack L. Carey · 2017 · Pharmacology Biochemistry and Behavior
  80. The Role of the Gut in Parkinsons Disease
    Dominic Adam Worku, Roseanna Matt · 2019 · European Journal of Experimental Biology
  81. Microbiota and Parkinson's disease (overview)
    R. R. Tyutina, Anna A. Pilipovich, В Л Голубев, Alexey B. Danilov · 2020 · Medical alphabet
  82. The contribution of gut microbiota in the pathogenesis of Parkinson’s disease
    Tahira Farooqui · 2021 · Elsevier eBooks
  83. GUT-MICROBIOME-BRAIN AXIS AND ITS INFLUENCE ON PARKINSON'S DISEASE (Review Article)
    JYOTHIS SUSAN SAJI, SUNIL SHARON, ROBINSON TRINITA, BASHEER SAFAR, KAND I KAVIL, Tamar Akhvlediani · 2022 · EXPERIMENTAL & CLINICAL MEDICINE GEORGIA
  84. RNA-based stable isotope probing provides no indication for rapid α-synuclein assimilation by murine gut bacteria
    Lena Brandau, Severin Weis, Maximilian Weyland, Fabian K. Berger, Sylvia Schnell, Karl‐Herbert Schäfer, Markus Egert · 2022 · Access Microbiology
  85. Esquizofrenia e Neuroinflamação: Uma revisão das pesquisas recentes que exploram as conexões entre a esquizofrenia e processos de neuroinflamação, abrindo caminho para novas estratégias terapêuticas.
    Verônica de Souza Martins, Natália Maria Riera Pimenta, Matheus Pereira Vieira, Gustavo de Godoi Teixeira, Victor Scaglioni Reis Brito · 2023 · Brazilian Journal of Implantology and Health Sciences
  86. Comparison of phage and plasmid populations present in the gut microbiota of Parkinson’s disease patients
    Alexandre Lecomte, Ilhan Cem Duru, Pia Laine, Tânia Keiko Shishido, Joni Suppula, Lars G. Paulin, Filip Scheperjans, Pedro A. B. Pereira, Petri Auvinen · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  87. Novel Theranostics for Parkinson's Disease
    Benjamin William Schlichtmann · 2021
  88. Gut-Brain Interplay and Cognitive Degeneration
    Kalaiselvi Krishnamoorthy, Ponnulakshmi Rajagopal, Selvaraj Jayaraman · 2024 · Springer eBooks
  89. Introduction to Gut Microbiota and their Effects on Various Brain Disorders
    Afreen Usmani, Anuradha Mishra · 2024 · BENTHAM SCIENCE PUBLISHERS eBooks
  90. Dietary Constituents for Mental Health Promotion and Healthy Ageing
    Khetan Shevkani · 2024 · Healthy ageing and longevity
  91. Study of intestinal microbiota in Parkinson’s disease
    Abderrahmane Achbani, Aya Ait Quirrou, Fatima Zouhra Aoukted, Nouhaila Boulihiya, Youssef Bouchriti, Ahmed Kharbach, Hayat Sine, Abdelaziz Ait Melloul, Jamila Rida, Hasnaa Sine · 2024 · International Journal of Environmental Studies
  92. Crosstalk between gut-brain axis and brain components along with associated neurological disorders
    Priya Bindal, Swati Kaushal, Charan Singh, Arti Singh · 2025 · Elsevier eBooks
  93. Therapeutic Potential of Pistachio Green Hull Extract in Treating Parkinson's Disease: A Comprehensive In Vivo and In Vitro Investigation
    Maedeh Tavakoli, Negin Mohammadi, Mohsen Barzegar · 2025 · Food Science & Nutrition
  94. Research Progress on the Effect of Thesium chinense Turcz. on Neurodegenerative Diseases
    Ziyi Li, Yanfang Zhao, Rong Wang, Ruoxuan Zhou, Xuehua Chen, Jingchen Jiang, Yilan Dai, Huaiqing Luo · 2025 · International Journal of Molecular Sciences
  95. A 15-year bibliometric analysis of body mass index moderation in the management of Parkinson’s disease
    Qiying Liu, Ying Chen, Shuyi Chen · 2025 · Frontiers in Aging Neuroscience
  96. Neuropsychological Assessments and Neurodegenerative Disorders
    Ines Tchienga, Brittany Heavens · 2025 · IntechOpen eBooks
  97. Research Progress of Correlation between Parkinson’s Disease and Ghrelin and Leptin
    Jian-Gang Liu · 2024 · Advances in Clinical Medicine
  98. Study of neuronal networks and mechanisms implicated in locomotor reactivity and Parkinson's disease pathogenesis in the Drosophila model
    Jun Sun · 2018 · theses.fr (ABES)
  99. Pathological Remuneration of Oxidative Stress in Limiting Gut-Brain Axis
    Rohit Kumar, Akash Kashyap, Saba Naqvi · 2026 · Oxidative stress in applied basic research and clinical practice
  100. Caffeine as a modulator of neurodegenerative processes: molecular targets, dose-dependent effects, and the influence of genetic polymorphism
    F A Yusupov, M.Sh. Abdykadyrov · 2026 · Russian Journal of Preventive Medicine